Drug Discovery World

SEPTEMBER 25, 2024

DISCO’s approach is to analyse the “surfaceome” of cancer cells – the totality of all proteins expressed on the cell surface – looking for ways that diseased tissue is differentiated from normal tissue. Ries noted that there are other things to think about aside from finding targets expressed only on tumour cells. .”

Therapies 162

Therapies Pharma Companies FDA Approval FDA 162

Drug Discovery World

NOVEMBER 30, 2023

This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7 kb Influenza A hemagglutinin gene was used as a model system.

Protein Expression 147

Protein Expression Engineering DNA Therapies 147

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion.

Engineering 147

Engineering Science Bioinformatics Vaccine 147

Drug Discovery World

NOVEMBER 9, 2023

Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. Lena Tholen, Director, Cell line and Bioprocess Development, FyoniBio, on: ‘Fyonibio’s versatile cell line expression platforms for the development of complex molecules’.

Engineering 130

Engineering Therapies Protein Production Science 130